SEC Filing Summary: Intrexon Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Intrexon Corporation on April 12, 2019. The report addresses a corporate event involving the resale of common stock issued under a Securities Purchase, Assignment and Assumption Agreement dated December 19, 2018, between Intrexon, Ares Trading S.A., and Precigen, Inc. (a wholly owned subsidiary of Intrexon).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure regarding securities resale and does not contain financial performance data.
Material Changes
The material event reported is the filing of a prospectus supplement on Form S-3 (File No. 333-220326) covering the resale of shares of Intrexon common stock. This action facilitates the distribution of shares previously issued to Ares Trading S.A. and Precigen, Inc.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. No specific risks or contingencies are detailed in this document beyond the standard legal opinion regarding the securities resale.
Investor Verification Checklist
- Verify the details of the Securities Purchase, Assignment and Assumption Agreement dated December 19, 2018.
- Review the prospectus supplement filed on Form S-3 (File No. 333-220326) for terms regarding the resale of shares.
- Confirm the legal opinion provided by Hogan Lovells US LLP (Exhibit 5.1) regarding the validity of the share resale.
- Check subsequent filings for any financial impact resulting from the share resale.